Science & tech

The Medical Minute: Cannabis Curbs Fear & Sadness, But Questions Remain

Published on September 10, 2013 · Last updated July 28, 2020

Dr. Dominic Corva once stated that cannabis legality is the "politics of knowledge." Until recently, the availability of trustworthy information regarding cannabis science has been limited. Fortunately, with decriminalization comes the advent of cannabis-related research, and more importantly, funding to back it.

Because not everyone has a doctorate in neurology and/or the time to decipher dense, technical documents, the Leafly Content Team will provide regular roundups to keep you up to date on poignant medical discussion surrounding the cannabis industry, with a focus on journal articles and academic publications.

This week, our "Medical Minute" roundup covers cannabis as a treatment for anxiety and depression, a potential therapeutic testing capability, and health and societal concerns associated with cannabis legalization.

1. Be Bold, Be Brave: Cannabis Calms Fears

Like cannabis, the fatty acid amide hydrolase (FAAH) was identified to decrease fear and anxiety by increasing endocannabinoid levels. Both mice and human studies determined the FAAH gene to directly influence the subject’s ability to get over bad experiences. This finding supports cannabis’s therapeutic value for cases of mild anxiety to severe PTSD.

2. Canada Has Cannabis Worries

The Canadians continue to discuss cannabis’s place within society, forecasting development of ‘marijuana doctors’ and drawing parallels to tobacco.

  • Saskatchewan worries about the evolution of ‘marijuana doctors’, i.e., physicians known for prescribing cannabis to those without evidence of a qualifying medicinal need. Without tight federal reigns, those concerned call for any regulatory structure, which may end up necessitating documentation of all cannabis prescriptions.
  • Chatham-Kent’s medical officer of health calls marijuana safe with no physical addiction, but warns against psychological addiction, potential onset of schizophrenia with adolescent use, and the same lung-related ailments associated with tobacco use.

3. New Model May Allow Us to Test Cannabis’s Therapeutic Value

Speaking of schizophrenia (one of the top-ten debilitating diseases within developing countries), a model system was developed that will allow for testing of potential neurological therapies, like cannabis. The model allows for the assessment of a patient’s sensory integration, a primary source of dysfunction for schizophrenics and a factor in other neurological diseases.

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries

4. Antidepressant Value of Cannabis Supported by Neurological Discovery

A new drug target, the GABA neuron, has been identified. This neural activity has been linked to inhibition of serotonin, or happiness, which helps to explain the ineffectiveness of current antidepressants. The discovery could substantiate cannabis’s antidepressive value should they find cannabis interacts with GABA neural activity.

5. Chronic Cannabis Use with Adolescent Onset Decreases IQ

Like alcohol, nicotine, and cocaine, adolescent cannabis use is deemed neurologically harmful and permanently lowers IQ. Adult cannabis usage did not show similar mental decline. The optimal age and dosage for safe consistent cannabis use is unkown, but with these suggestive findings, should not precede adulthood.

photo credits: Shandi-leealbertogp123Taylor Dawn FortuneCuppojoePatrick Hoesly via photopincc

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
Kayla Williams
Kayla Williams
Kayla is a writer with an emphasis in holistic health, bioengineering, and nutrition/dietetics.
View Kayla Williams's articles
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play




* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.